Previous close | 6.80 |
Open | 6.70 |
Bid | 3.00 |
Ask | 9.70 |
Strike | 410.00 |
Expiry date | 2026-01-16 |
Day's range | 6.70 - 6.80 |
Contract range | N/A |
Volume | |
Open interest | 79 |
Strength in Analytical Instrument and Specialty Diagnostics segments is likely to have driven Thermo Fisher's third-quarter 2024 performance.
Myriad Genetics and Ultima Genomics to explore the latter's sequencing platform for advanced clinical tests in oncology and reproductive genomics.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.